Invitrogen™ Human TDP-43 Synthetic Peptide
TDP43 Synthetic Peptide, PEP-0526, from Invitrogen.
- Gene ID (Enter)
- 23435
- Species
- Human
- Purification method
- Purified
- Accession number
- Q13148
- Common name
- Human TDP-43
- Brand
- Invitrogen
TDP43 Synthetic Peptide, PEP-0526, from Invitrogen.
TDP43 Synthetic Peptide, PEP-0526, from Invitrogen.
TDP43 was first identified as a novel cellular protein that binds to HIV-1 virus TAR DNA sequence motifs and acts a transcriptional repressor to the HIV-1 LTR. Later experiments revealed that TDP43 also regulates the splicing of exon 9 of the cystic fibrosis transmembrane conductance regular (CFTR), most likely through the association with the UG repeats at the 3'e; splice site. A hyperphosphorylated, ubiquitinated, and cleaved form of TDP43 known as pathologic TDP43 is the major disease protein in ubiquitin-positive, tau-, and alpha-synuclein-negative frontotemporal dementia (FLTD-U). TDP43 is not related to TRBP1, and RNA binding protein that binds HIV-1 TAR RNA sequences.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15338650 |
| Specifications | |
| Gene ID (Enter) | 23435 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q13148 |
| Common name | Human TDP-43 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | TARDBP |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0526 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 96 00 |